Hedge funds are diving deeper into Asian markets, with Goldman Reports highlighting their highest exposure in five years. Between June 6 and June 12, global hedge funds ramped up trading volumes, pushing bullish positions to levels not seen since September 2024.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
OpenAI is trending in the news once more. This time, it’s about much more than ChatGPT or AI products. It’s about money and a lot of it. The company is aiming for a massive $500 billion valuation in its upcoming share sale. Yes, $500 billion. That’s more than the value of some entire industries. And…
Did you know that over 190 million Demat accounts are active in India? That number keeps growing as more people invest in stocks, mutual funds, and IPOs. This significant growth reflects the increasing participation of individuals in the financial markets. A Demat account is like a digital locker for our investments. It holds our shares…
On 7 January 2026, the UK’s main financial watchdog, the Financial Conduct Authority (FCA), fined two former finance directors of Carillion for issuing misleading statements about the company’s finances. The directors, Richard Adam and Zafar Khan, agreed to pay a total of £371,700 after they withdrew their challenges against the FCA’s findings. Continue Reading on…
Bpost, Belgium’s leading postal and logistics company, has given investors a reason to cheer. Its shares jumped 8% after the company posted stronger-than-expected Q2 results. Revenue was up, profits were solid, and management even raised its outlook for the rest of the year. In a market where many delivery companies are struggling with rising costs…
Fixed income investing is a cornerstone of many portfolios. You’ve probably heard the term before, but what exactly does it tell you about returns? In simple words, fixed income refers to investments that pay regular income, like bonds or certificates of deposit. Unlike stocks, which have unpredictable dividends or prices, fixed income aims to deliver…
The Rubicon Research IPO is one of the most anticipated public offerings in India’s pharmaceutical sector this year. Scheduled to open on October 9, 2025, and close on October 13, 2025, this IPO has garnered significant attention from investors. With a price band set between ₹461 and ₹485 per share, Rubicon Research aims to raise…